Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

被引：0
|
作者：
Schmidt, MK
van Sprundel, TC
Rookus, MA
Brohet, R
van Asperen, CJ
Rutgers, EJT
Tollenaar, RAEM
van't Veer, LJ
机构：
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
Breast Cancer; Contralateral Breast Cancer; BRCA2 Mutation Carrier; Mutation Testing; Contralateral Prophylactic Mastectomy;
D O I：
10.1186/bcr1096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [41] Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers
    Lowry, Kathryn P.
    Lee, Janie M.
    Kong, Chung Y.
    McMahon, Pamela M.
    Gilmore, Michael E.
    Chubiz, Jessica E. Cott
    Pisano, Etta D.
    Gatsonis, Constantine
    Ryan, Paula D.
    Ozanne, Elissa M.
    Gazelle, G. Scott
    CANCER, 2012, 118 (08) : 2021 - 2030
  • [42] Financial toxicity in BRCA1 and BRCA2 carriers
    Proussaloglou, Ellie M.
    Rosenthal, Alex E.
    Raker, Christina A.
    Wilbur, Jennifer Scalia
    Stuckey, Ashley R.
    Robison, Katina M.
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 160 - 166
  • [43] Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
    Akdeniz, Delal
    van Barele, Mark
    Heemskerk-Gerritsen, Bernadette A. M.
    Steyerberg, Ewout W.
    Hauptmann, Michael
    van de Beek, Irma
    van Engelen, Klaartje
    Wevers, Marijke R.
    Garcia, Encarnacion B. Gomez
    Ausems, Margreet G. E. M.
    Berger, Lieke P., V
    van Asperen, Christi J.
    Adank, Muriel A.
    Collee, Margriet J.
    Stommel-Jenner, Denise J.
    Jager, Agnes
    Schmidt, Marjanka K.
    Hooning, Maartje J.
    BREAST, 2022, 61 : 98 - 107
  • [44] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Jane C. Figueiredo
    Jennifer D. Brooks
    David V. Conti
    Jenny N. Poynter
    Sharon N. Teraoka
    Kathleen E. Malone
    Leslie Bernstein
    Won D. Lee
    David J. Duggan
    Ashley Siniard
    Patrick Concannon
    Marinela Capanu
    Charles F. Lynch
    Jørgen H. Olsen
    Robert W. Haile
    Jonine L. Bernstein
    Breast Cancer Research and Treatment, 2011, 127 : 819 - 829
  • [45] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Figueiredo, Jane C.
    Brooks, Jennifer D.
    Conti, David V.
    Poynter, Jenny N.
    Teraoka, Sharon N.
    Malone, Kathleen E.
    Bernstein, Leslie
    Lee, Won D.
    Duggan, David J.
    Siniard, Ashley
    Concannon, Patrick
    Capanu, Marinela
    Lynch, Charles F.
    Olsen, Jorgen H.
    Haile, Robert W.
    Bernstein, Jonine L.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 819 - 829
  • [46] Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Julia Krammer
    Katja Pinker-Domenig
    Mark E. Robson
    Mithat Gönen
    Blanca Bernard-Davila
    Elizabeth A. Morris
    Debra A. Mangino
    Maxine S. Jochelson
    Breast Cancer Research and Treatment, 2017, 163 : 565 - 571
  • [47] Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?
    Phillips, Kelly-Anne
    Lindeman, Geoffrey J.
    FUTURE ONCOLOGY, 2014, 10 (04) : 499 - 502
  • [48] Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers
    de Juan Jimenez, Inmaculada
    Esteban Cardenosa, Eva
    Palanca Suela, Sarai
    Barragan Gonzalez, Eva
    Bolufer Gilabert, Pascual
    CLINICAL BIOCHEMISTRY, 2009, 42 (15) : 1572 - 1576
  • [49] Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Antoniou, Antonis C.
    ENDOCRINE-RELATED CANCER, 2016, 23 (10) : T69 - T84
  • [50] An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers
    Madorsky-Feldman, Dana
    Sklair-Levy, Miri
    Perri, Tamar
    Laitman, Yael
    Paluch-Shimon, Shani
    Schmutzler, Rita
    Rhiem, Kerstin
    Lester, Jenny
    Karlan, Beth Y.
    Singer, Christian F.
    Van Maerken, Tom
    Claes, Kathleen
    Brunet, Joan
    Izquierdo, Angel
    Teule, Alex
    Lee, Jong Won
    Kim, Sung-Won
    Arun, Banu
    Jakubowska, Anna
    Lubinski, Jan
    Tucker, Katherine
    Poplawski, Nicola K.
    Varesco, Liliana
    Bonelli, Luigina Ada
    Buys, Saundra S.
    Mitchell, Gillian
    Tischkowitz, Marc
    Gerdes, Anne-Marie
    Seynaeve, Caroline
    Robson, Mark
    Kwong, Ava
    Tung, Nadine
    Tessa, Nalven
    Domchek, Susan M.
    Godwin, Andrew K.
    Rantala, Johanna
    Arver, Brita
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (02) : 319 - 327
12345